A multicenter, open-label, exploratory study to evaluate the efficiency of intravenously administered cyclosporine during the first 7 days post transplant followed by treatment with cyclosporine micro emulsion in de novo liver transplant recipients
Phase of Trial: Phase IV
Latest Information Update: 04 Mar 2011
At a glance
- Drugs Ciclosporin (Primary)
- Indications Liver transplant rejection
- Focus Therapeutic Use
- Sponsors Novartis
- 03 Nov 2009 Actual end date (Jan 2009) added as reported by ClinicalTrials.gov.
- 03 Nov 2009 Actual patient number (34) added as reported by ClinicalTrials.gov.
- 03 Nov 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.